Asia’s emergence as a global hub for biotech and medtech is accelerating – and HKUMed – The University of Hong Kong is proud to help drive this momentum.

Our Assistant Dean (Innovation & Technology Transfer), Prof. Joshua W. K. Ho, recently participated in the BioCentury-BayHelix East-West Biopharma Summit in Seoul, co-sponsored by HKSTP, where he joined regional leaders to discuss how Asia can translate scientific excellence into investable biotech and medtech opportunities.

At the “Hong Kong Breakfast Workshop: From Innovation to Capital Valuation – Making Asia’s Biotech Investable,” Prof. Ho highlighted how Hong Kong’s deep talent pool in biotechnology, AI, medical technology and biomedical engineering is powering a new generation of health innovations. He also underscored the importance of cross-disciplinary and cross-border collaboration in turning academic breakthroughs into real-world impact for patients. 

The HKUMed Technology Transfer Unit is committed to:
🔬 Empowering researchers and clinicians to commercialize their discoveries
🤝 Building partnerships with industry, investors and incubators across Asia and beyond
🚀 Supporting an innovation ecosystem that connects science, entrepreneurship and global markets

We welcome collaborators who share our vision of bringing university innovations from bench to bedside.

🔗 To explore partnership opportunities with HKUMed from an innovation and technology transfer perspective, please contact the HKUMed Technology Transfer Unit | TTU at infottu@hku.hk.